U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07453225) titled 'Empirical Radioactive Iodine Therapy in DTC' on Feb. 25.
Brief Summary: The aim of the study is assessment the efficacy of empiric RAI therapy in DTC patients with elevated thyroglobulin levels and negative iodine scintigraphy.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Differentiated Thyroid Cancer
Intervention:
DRUG: Radioactive Iodine Therapy
empirical dose of RAI
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): Mona Nabil Helbawi, Assiut University
Published by HT Digital Content Services with permission from Health Daily Digest....